Clinical Trial Update: Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety of low-dose intravenous contrast CT scanning in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Lung Cancer
• Pulmonary Embolism
• Renal Artery Stenosis

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Chronic Kidney Disease, Pulmonary Embolism | Phase 4 | Status: COMPLETED